Literature DB >> 30710710

In vivo analysis of a first-in-class tri-alkyl norspermidine-biaryl antibiotic in an active release coating to reduce the risk of implant-related infection.

Dustin L Williams1, Richard T Epperson2, Nicholas N Ashton2, Nicholas B Taylor2, Brooke Kawaguchi2, Raymond E Olsen2, Travis J Haussener3, Paul R Sebahar3, Gina Allyn2, Ryan E Looper4.   

Abstract

Prosthetic joint infection (PJI) is a well-known and persisting problem. Active release coatings have promise to provide early protection to an implant by eradicating small colony biofilm contaminants or planktonic bacteria that can form biofilm. Traditional antibiotics can be limited as active release agents in that they have limited effect against biofilms and develop resistance at sub-lethal concentrations. A unique first-in-class compound (CZ-01127) was assessed as the active release agent in a silicone (Si)-based coating to prevent PJI in a sheep model of joint space infection. Titanium (Ti) plugs contained a porous coated Ti (PCTi) region and polymer-coated region. Plugs were implanted into a femoral condyle of sheep to assess the effect of the Si polymer on cancellous bone ingrowth, the effect of CZ-01127 on bone ingrowth, and the ability of CZ-01127 to prevent PJI. Microbiological results showed that CZ-01127 was able to eradicate bacteria in the local region of the implanted plugs. Data further showed that Si did not adversely affect bone ingrowth. However, bacteria that reached the joint space (synovium) were not fully eradicated. Outcomes suggested that the CZ-01127 coating provided local protection to the implant system in a challenging model, the design of which could be beneficial for testing future antimicrobial therapies for PJI. STATEMENT OF SIGNIFICANCE: Periprosthetic joint infection (PJI) is now commonplace, and constitutes an underlying problem that patients and physicians face. Active release antibiotic coatings have potential to prevent these infections. Traditional antibiotics are limited in their ability to eradicate bacteria that reside in biofilms, and are more susceptible to resistance development. This study addressed these limitations by testing the efficacy of a unique antimicrobial compound in a coating that was tested in a challenging sheep model of PJI. The unique coating was able to eradicate bacteria and prevent infection in the environment adjacent to the implant. Bacteria that escaped into the joint space still caused infection, yet benchmark data can be used to optimize the coating and translate it toward clinical use. Published by Elsevier Ltd.

Entities:  

Keywords:  Bone ingrowth; CZ-01127; Coating; Drug delivery; Implant; Silicone

Mesh:

Substances:

Year:  2019        PMID: 30710710     DOI: 10.1016/j.actbio.2019.01.055

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  3 in total

1.  Lytic Bacteriophage as a Biomaterial to Prevent Biofilm Formation and Promote Neural Growth.

Authors:  Zi-Hao Liu; Ming-Tse Chiang; Hsin-Yi Lin
Journal:  Tissue Eng Regen Med       Date:  2022-06-01       Impact factor: 4.451

2.  Biofilm Growth on Simulated Fracture Fixation Plates Using a Customized CDC Biofilm Reactor for a Sheep Model of Biofilm-Related Infection.

Authors:  Walker Kay; Connor Hunt; Lisa Nehring; Brian Barnum; Nicholas Ashton; Dustin Williams
Journal:  Microorganisms       Date:  2022-03-31

3.  Protecting the skin-implant interface with transcutaneous silver-coated skin-and-bone-integrated pylon in pig and rabbit dorsum models.

Authors:  Maxim Shevtsov; Dmitriy Gavrilov; Natalia Yudintceva; Elena Zemtsova; Andrei Arbenin; Vladimir Smirnov; Irina Voronkina; Polina Adamova; Miralda Blinova; Nataliya Mikhailova; Oleg Galibin; Michael Akkaoui; Mark Pitkin
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2020-09-16       Impact factor: 3.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.